QT
ABUS icon

Quantbot Technologies’s Arbutus Biopharma ABUS Stock Holding History

Quantbot Technologies’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-89
Closed – – 1041
2015
Q3 		$0 Sell
89
-311
-78% -$2.76K ﹤0.01% 1160
2015
Q2 		$4K Sell
400
-100
-20% -$1.52K ﹤0.01% 1035
2015
Q1 		$8K Buy
+500
New +$10.2K ﹤0.01% 968
2014
Q4 		– Sell
-7,432
Closed -$157K – 1084
2014
Q3 		$157K Buy
+7,432
New +$121K 0.02% 775
2014
Q2 		– Sell
-1,200
Closed -$25K – 1126
2014
Q1 		$25K Buy
+1,200
New +$21.6K 0.01% 926

Other funds holding ABUS

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Quantbot Technologies's ABUS Position: Q4 2015 in Review

Quantbot Technologies sold out of Arbutus Biopharma (ABUS) in Q4 2015, closing a stake of 89 shares.

Quantbot Technologies first reported a position in ABUS in Q1 2014 and held it in 5 quarters. The position peaked at $157K in Q3 2014. 51 funds tracked by Wall St. Rank hold ABUS as of Q4 2015.

  • Quantbot Technologies reported no remaining Arbutus Biopharma position as of Q4 2015 after selling out during the quarter.
  • Quantbot Technologies sold 89 Arbutus Biopharma shares in Q4 2015.
  • Quantbot Technologies first reported a position in Arbutus Biopharma in Q1 2014 and held it in 5 quarters.
  • Quantbot Technologies's Arbutus Biopharma position peaked at $157K in Q3 2014.
  • 51 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2015.

Based on Quantbot Technologies's 13F filing for Q4 2015, filed 22 Jan 2016.